Bronchiolitis is a viral-induced lower respiratory tract infection that occurs predominantly in children <2 years of age, particularly infants. Many viruses have been proven or attributed to cause bronchiolitis, including and most commonly the respiratory syncytial virus (RSV) and rhinovirus. Bronchiolitis may be diagnosed on the basis of clinical signs and symptoms. In a young child, the diagnosis can be made on the clinical pattern of wheezing and hyperinflation.
Clinical symptoms and signs typically start with an upper respiratory prodrome, including rhinorrhoea, low-grade fever, cough and poor feeding, followed 1 -2 days later by tachypnoea, hyperinflation and wheeze as a consequence of airway inflammation and air trapping. [1] The illness is generally self limiting, but may progressively become more severe and include signs such as grunting, nasal flaring, subcostal chest wall retractions and hypoxaemia. [2] The most reliable clinical feature of bronchiolitis is hyperinflation of the chest, evident by loss of cardiac dullness on percussion, an upper border of the liver pushed down to below the 6th intercostal space, and the presence of a Hoover sign (subcostal recession, which occurs when a flattened diaphragm pulls laterally against the lower chest wall).
Measurement of peripheral arterial oxygen saturation is useful to indicate the need for supplemental oxygen. A saturation of <92% at sea level and 90% inland indicates that the child requires hospital admission for supplemental oxygen.
Investigations Chest radiographs
Chest radiographs (CXRs) are generally unhelpful and not required in children with a clear clinical diagnosis of bronchiolitis.
Risk of airspace disease appears to be particularly low in children with saturation >92% and with mild to moderate distress. [3] A temperature ≥38°C has been shown to be a clinical predictor of radiographic abnormalities. [4] CXRs in bronchiolitis show signs of hyperinflation, peribronchial thickening or patchy areas of consolidation and collapse, which may be confused with signs of pneumonia. A CXR should only be done in the following instances: [2, 4, 5] • if complications are suspected, e.g. pleural effusion or pneumothorax • severe cases • temperature ≥38°C Bronchiolitis may be diagnosed on the basis of clinical signs and symptoms. In a young child, the diagnosis can be made on the clinical pattern of wheezing and hyperinflation.
Clinical symptoms and signs typically start with an upper respiratory prodrome, including rhinorrhoea, low-grade fever, cough and poor feeding, followed 1 -2 days later by tachypnoea, hyperinflation and wheeze as a consequence of airway inflammation and air trapping.
The illness is generally self limiting, but may become more severe and include signs such as grunting, nasal flaring, subcostal chest wall retractions and hypoxaemia. The most reliable clinical feature of bronchiolitis is hyperinflation of the chest, evident by loss of cardiac dullness on percussion, an upper border of the liver pushed down to below the 6th intercostal space, and the presence of a Hoover sign (subcostal recession, which occurs when a flattened diaphragm pulls laterally against the lower chest wall).
Measurement of peripheral arterial oxygen saturation is useful to indicate the need for supplemental oxygen. A saturation of <92% at sea level and 90% inland indicates that the child has to be admitted to hospital for supplemental oxygen. Chest radiographs are generally unhelpful and not required in children with a clear clinical diagnosis of bronchiolitis.
Blood tests are not needed routinely. Complete blood count tests have not been shown to be useful in diagnosing bronchiolitis or guiding its therapy. Routine measurement of C-reactive protein does not aid in management and nasopharyngeal aspirates are not usually done. Viral testing adds little to routine management.
Risk factors in patients with severe bronchiolitis that require hospitalisation and may even cause death, include prematurity, congenital heart disease and congenital lung malformations. 
Haematology
Blood tests are not needed routinely. Complete blood count tests have not been shown to be useful in diagnosing bronchiolitis or guiding its therapy. [2] Routine measurement of C-reactive protein does not aid in management. [6] If the infant appears severely ill, consider alternative diagnoses (bacterial co-infection and other causes of airway obstruction). Clinical signs of concern include pallor, lethargy, severe tachycardia, high temperature, hypotonia or seizures. In cases of serious sepsis investigations may include a CXR, blood culture, and urinary and cerebrospinal fluid analysis. [5] 
Nasopharyngeal aspirates
Nasopharyngeal aspirates (NPAs) are not usually taken and viral testing adds little to routine management, [7] but NPAs are needed to inform surveillance, measuring burden of disease and also in the following cases: [5, 7] • neonates (<1 month) • history of apnoea with illness • bed management to allow cohorting of patients.
NPAs should be immersed in viral transport medium at 4 -8°C and transported to an appropriate laboratory within 72 hours of collection. Specimens should be tested by multiplex real-time reverse-transcription polymerase chain reaction (rRT-PCR) assay for respiratory viruses. Comparative studies have shown that rRT-PCR assays are sub stantially more sensitive than conventional methods, such as viral culture and immuno fluorescence assays, for detecting respiratory viruses. [8] Furthermore, multiplex rRT-PCR has a significant advantage, as it permits simultaneous amplification of several viruses in a single reaction, facilitating a cost-effective diagnosis. [8] 
Risk factors for severe disease
In infants and young children respiratory viruses have the propensity to produce more serious lower respiratory tract illnesses, bronchiolitis and pneumonia. Infants <1 year of age are at greatest risk of bronchiolitis, and the disease is more severe when risk factors are present (Table 1) . [9] [10] [11] [12] [13] [14] [15] Debate about the importance of respiratory syncytial virus infection as a cause of hospitalisation in late preterm infants has raged because of the cost of prophylactic therapy. Recent reports have suggested that these infants are at equal risk and require prophylaxis. [16, 17] South African studies have revealed that the mean duration of symptoms following bronchiolitis was 12 days (95% confidence interval 11 -14 days). After 21 and 28 days, 18% and 9%, respectively, were still ill. Thirty-four percent of these children were seen by a physician during an unscheduled visit. [18] Finally, the respiratory viruses, especially RSV, may predispose to recurrent episodes of wheezing and possibly asthma. [19, 20] 
Differential diagnosis
The differential diagnosis of respiratory symptoms is wide, but where hyperinflation and wheeze occur the conditions listed in Table 2 should be considered. 
